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Abstract
About 200 journal articles reported research on Tourette syndrome and other
tic disorders in 2014. Here we briefly summarize a few of the reports that
seemed most important or interesting, ranging from animal models to human
studies. Readers can comment on our choices or provide their own favorites
using the tools on the online article.
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Introduction
The available information on Tourette syndrome (TS) is steadily 
increasing (Figure 1), and keeping up with the published litera-
ture is therefore an increasing challenge. This article introduces a 
Highlights article to the F1000Research: Tics channel, to show-
case some of the most noteworthy publications from the previous 
calendar year.
Methods
This article is not a systematic review but summarizes the authors’ 
personal views. We used the following approach to identify per-
tinent publications: personal reading, asking colleagues for sug-
gestions, F1000Prime, and a PubMed search (Figure 1, legend). 
The search string “(“Tic Disorders”[MeSH] OR Tourette NOT 
Tourette[AU]) AND 2014[PDAT] NOT 2015[PDAT]” produced 
201 references (one of which was actually published in 2013). Of 
course this approach will miss some TS-related publications that do 
not appear in PubMed, or that will be indexed in PubMed in coming 
months. We further limited the scope to articles written in English 
that had final publication dates in 2014.
Dataset 1. Publications on Tourette syndrome: 1950–2014
http://dx.doi.org/10.5256/f1000research.6209.d79935
This file contains the PubMed data used to generate Figure 1 in the 
associated article.
Results
Here we present examples of TS research published in 2014 that we 
thought had notable findings or the potential to stimulate additional 
research in TS.
Etiology
A genetic clue. To this point, the highly heritable nature of TS has 
remained a tantalizing clue rather than the key to understanding 
pathophysiology. However, recently an international collaboration 
reported an intriguing result. A recent genome-wide association 
study had identified a number of single nucleotide polymorphisms 
(SNPs) as possibly associated with TS. The group genotyped 42 of 
these SNPs in over 1200 individuals, half from unrelated TS cases 
and half from controls matched for ancestry69. A risk score based on 
each individual’s alleles at the 42 SNPs was able to predict diagno-
sis significantly better than chance; this result supports the conclu-
sion that at least some of these SNPs are true risk alleles for TS. 
One of the SNPs remained significant after correction for multiple 
comparisons, and the authors discuss nearby genes that could pro-
duce relevant changes in brain structure or function.
Pathophysiology
Mice without histamine. Castellan Baldan et al.1,2 report on charac-
terization of a possible animal model for Tourette syndrome, chosen 
because of a family with Tourette syndrome linked to a loss-of-function 
mutation in the histidine decarboxylase gene3,4. Histidine decar-
boxylase knock-out mice5 exhibited tic-like stereotypies after 
a d-amphetamine challenge (see Figure 1, panel E in ref. 2) and 
increased striatal dopamine during the nocturnal (awake) period. 
The amphetamine-induced stereotypies were decreased by admin-
istration of the dopamine D2 receptor antagonist haloperidol, and 
histamine infusion reduced striatal dopamine levels and amphet-
amine-induced stereotypies. Prepulse inhibition and dopamine 
D2/D3 receptor binding were altered in both the knock-out mice 
and the small sample of known human carriers of the histidine 
decarboxylase mutation.
Other animal models. Appropriate animal models of TS could pro-
vide pathophysiological insights or speed identification and devel-
opment of novel treatments. Two informative reviews of mouse 
models for tic disorders were published in 20146,7. Both reviews 
agreed that animal models need appropriate face, constructive, and 
predictive validity to be useful, but Godar et al. argue that a focus 
      Amendments from Version 1
We revised the article to address the thoughtful comments by the 
two reviewers. We added most of the suggested references into 
the text or Box 1; suggested articles with final publication dates in 
2015 appear in Box 2. Readers can find additional citations in the 
reviewers’ comments. We had inadvertently omitted the ecopipam 
reference that both reviewers suggested, and we remedy that 
now in a new section on pharmacotherapy. We also added 
comments on DBS, and added the recent consensus statement 
to Box 2. We reorganized the papers by theme, as suggested. 
We also corrected Figure 1 and supply with it the updated iPython 
notebook file and the HTML copy. Replies to specific reviewer 
comments appear in the “Author Response” boxes below.
See referee reports
REVISED
Figure 1. Publications on Tourette syndrome. The number of new 
publications on Tourette syndrome or other tic disorders each year 
was estimated from PubMed. The colored line represents locally 
weighted scatterplot smoothing (LOWESS) of the primary data.
PubMed was searched using the search string “(“Tic Disorders”[MeSH] 
OR Tourette NOT Tourette[AU]) AND year[PDAT] NOT year+1[PDAT]” 
for each year from 1950 through 2014. (This strategy assigns articles 
to the year in which the final publication appeared, to prevent double-
counting “early online” and final publication dates for about 250 
publications since 2005). The graph was generated by matplotlib in 
python (see Supplementary material).
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on intermediate phenotypes, which involve more elemental neu-
roanatomic and functional deficits, results in animal models with 
specific measurable parameters6. They then describe several lines of 
knockout mutant mice using candidate genes for TS, animal models 
examining the link between early neuroinflammation and TS patho-
genesis, and pharmacological models. Pappas et al. include mouse 
models for Rett’s syndrome and primary dystonia in addition to 
TS/OCD7. They developed a test battery to characterize variations 
across mouse strains in terms of putative tic-like symptoms (i.e., 
head twitches and body jerks induced by administration of a selec-
tive 5-HT2 receptor agonist), amphetamine-induced stereotypies 
(i.e., wall-rearing and head-down sniffing), perseverative respond-
ing on an attentional set-shifting task involving binary choice, and 
spontaneous locomotion8. Although DOI administration produced 
head twitches and body jerks in all subjects, the SJL and C57 mice 
spent a longer time performing body jerks than the ABH and CD1 
mouse strains, with the C57 mice also showing increased elevated 
levels of spontaneous locomotion and increased perseveration on 
the set-shifting task. The authors argue that using specific behavio-
ral parameters to investigate differences among mouse strains will 
allow identification of strains that may represent “pure” TS while 
other strains may represent TS along with behaviors that reflect 
common co-morbidities (e.g., hyperactivity, compulsions).
At the November, 2014, annual meeting of the Society for Neuro-
science, Xu et al. presented evidence that removing about half of 
the cholinergic interneurons in the dorsolateral striatum reproduced 
some features of TS in a rodent model9; see also10. This model was 
inspired by the fascinating autopsy studies that found decreased 
numbers of striatal interneurons in Tourette syndrome11. At the 
same meeting, McCairn and colleagues presented a non-human pri-
mate model with the GABA antagonist bicuculline injected into the 
putamen or nucleus accumbens; this produced a variety of move-
ments and vocalizations, including some tics with reasonable face 
validity12. As the validity of animal models increases, so does the 
expectation that they may provide additional insights concerning 
TS and its associated comorbidities.
A look inside: neuroimaging studies. Neuner et al.13 examined tic-
related neural activity in ten adults with TS using fMRI, estimat-
ing the timing of brain activity (as reflected by BOLD signal) to a 
resolution shorter than that of the individual image acquisitions by 
taking advantage of the essentially random temporal distribution of 
tics with respect to the timing of image acquisition. This strategy is 
reminiscent of the event-related analysis of positron emission tom-
ography regional brain blood flow images developed by Silbersweig 
and colleagues14. Two seconds before tic occurrence, BOLD activity 
increased in the supplementary motor area (SMA), ventral primary 
motor cortex, primary sensorimotor cortex and parietal operculum. 
One second before tics, activation was seen in the anterior cingu-
late, putamen, insula, amygdala, cerebellum and extrastriatal visual 
cortex, and at tic onset activation was seen in the primary motor 
and somatosensory cortices, the thalamus, and the central oper-
culum. Cortical structure BOLD signal clearly preceded signal in 
subcortical structures. In addition, resting state data demonstrated 
that network strength in the same SMA regions correlated with rat-
ings of recent tic severity; the authors suggest that abnormal base-
line activity in the SMA may contribute to tic generation. Diffusion 
tensor imaging identified lower connectivity values (CI), consist-
ent with altered white matter structure, in almost two-thirds of the 
tracts examined in 15 adults with “pure” TS compared to healthy 
controls15. After correction for multiple comparisons, 10 tracts were 
identified as having significantly lower CI in the patient group. Two 
of these involved connections between the SMA or preSMA and 
pallidum, and were excluded from further analysis. Correlations 
between YGTSS scores and individual tract CI values were found 
for the M1–OFC and preSMA–putamen, although none of these 
remained significant after correcting for multiple comparisons.
In another fMRI study, adults with “pure” TS performed similarly to 
control subjects on a stop signal reaction time task, consistent with 
the conclusion that tics occur without broadly insufficient action 
inhibition16. However, TS subjects exhibited greater dorsal premo-
tor activation during the Go condition compared to the StopSuccess 
condition. Increased right pre-SMA activation was associated with 
successful stop trials in healthy controls. For TS subjects, activation 
in the SMA proper during StopSuccess compared to Go trials was 
positively correlated with motor tic frequency. The involvement of 
SMA in both proactive and reactive control was discussed and the 
authors suggest that greater SMA activation in patients with higher 
tic frequency may reflect a stronger need for tic inhibition.
An overview of SMA syndromes and related research explores 
how the SMA may be involved in both initiation and inhibi-
tion of movements along with providing a tonic interhemispheric 
balance17. This concept of interhemispheric balance may explain 
why both SMA activation and SMA inhibition can reduce tics, and 
may also explain why SMA activation can produce echophenomena 
in healthy controls.
A derived measure called regional homogeneity (“ReHo”) in the left 
inferior frontal gyrus increased in 14 subjects with pure TS during tic 
suppression compared to free ticcing18. ReHo increases were posi-
tively correlated with participants’ ability to inhibit their tics both 
inside and outside the scanner. In another report from the same group, 
grey matter volumes in the right inferior frontal gyrus and left frontal 
pole were reduced in adults with “pure” TS compared to healthy con-
trols but these reductions were not correlated with Yale Global Tic 
Severity Scale (YGTSS) scores or the ability to inhibit tics19.
GABA concentrations in the SMA, measured using magnetic reso-
nance spectroscopy, were significantly higher in 15 adolescents with 
TS compared to 14 age- and gender-matched controls; there were no 
group differences for GABA concentrations within M1 or primary 
visual cortex20. The fMRI BOLD signal change within SMA was 
negatively correlated with SMA GABA levels supporting the idea 
that Magnetic Resonance Spectroscopy (MRS)-GABA concentra-
tions are associated with localized increases in tonic inhibition. In a 
small subset of TS subjects, single-pulse transcranial magnetic stim-
ulation (TMS) delivered to the hand area of the left M1 region pre-
ceding movement of the right hand revealed a significant negative 
correlation between MRS-GABA in the SMA and cortical-spinal 
excitability within the left M1. Fractional anisotropy values within 
the corpus callosum for TS subjects were positively correlated with 
the SMA GABA values and with motor tic severity. These authors 
suggest that enhanced control over volitional movements and tic 
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suppression may be the result of increased tonic inhibition due to 
the localized increases in extracellular GABA within SMA.
Eight adult subjects who completed Comprehensive Behavioral 
Intervention for Tics (CBIT) treatment were compared with matched 
controls on a visual priming task that was used to measure response 
inhibition21. No significant between-group differences were found 
in task-related BOLD signal in regions of interest (putamen, cau-
date, and prefrontal cortex regions BA 11, 44 and 47) before or 
after CBIT training (with retesting over a comparable amount of 
time for controls). However, there was a significant group by time 
interaction because putamen activation decreased in the TS subjects 
from time 1 to time 2 while it increased in the control subjects. A 
significant negative correlation between change in inferior frontal 
gyrus activation and change in YGTSS Total Tic Scores was also 
found. The authors point out that this result is somewhat difficult to 
interpret given that prior research has indicated that frontal regions 
are involved in tic suppression.
Caveats... Several groups have recently studied the substantial effects 
small head motions can have on BOLD fMRI. It is becoming appar-
ent that many of the established techniques to control for movement 
effects are frequently not sufficient. Functional connectivity analy-
ses have been especially affected, since small head movements dur-
ing scanning can produce artifactual connectivity signal (i.e., bias 
not just noise). Fortunately, robust methods exist for preventing such 
artifact, at the cost of potentially longer acquisition times22. How-
ever, movement also interferes with task fMRI analysis. In one task 
fMRI study of 73 TS subjects ranging in age from 9–15 years of age, 
only 38 subjects remained after excluding subjects with less than 
70% accuracy on a rule-switching task and with at least 3 runs out of 
6 with root-mean-square head movement estimates below 1.5 mm23. 
This is not all explained by tics, since 33 of 53 healthy, tic-free chil-
dren aged 7–9 were excluded for task accuracy <60% or head motion 
> 1.5 mm (rms). Even with these relatively stringent requirements, 
frame-by-frame motion censoring excluded an additional 15–20% 
of the data. However, this approach bought cleaner signal; motion 
censoring performed better than all forms of motion regression23.
Minor head motion has been shown to affect structural brain imag-
ing as well. Diffusion MRI is especially sensitive to motion24. A 
recent study showed that small head movements that do not cause 
visible artifact in structural brain images can also produce spurious 
reductions in estimated gray matter volume or cortical thickness25.
Many studies provide minimal information about the specific meth-
ods used to control for movement in a patient population that by defi-
nition is going to exhibit more movement than the average subject. 
Therefore inadequate control of subject movement may have contrib-
uted to some of the inconsistent results in past neuroimaging studies.
Phenomenology and natural history
The urge made me do it. Premonitory urges have been considered 
to have an important role in tic generation, and CBIT includes using 
a competing response to prevent a tic from occurring until the urge 
decreases sufficiently so that the tic will not occur. A number of 
articles in 2014 addressed how premonitory sensations and urges 
relate to tics and tic suppression.
Capriotti et al.33 examined the effects of negative reinforcement 
on premonitory urges in 13 children and adolescents with TS or 
chronic tic disorder (CTD). Subjects rated their urges to tic dur-
ing three conditions: baseline during which they freely ticced, rein-
forced tic suppression and reinforced tic suppression with escape. 
During the escape condition, subjects could initiate a 10 second 
break during which they could freely tic. When the break was over, 
the reinforced tic suppression began again. Tic rates were signifi-
cantly lower during reinforced suppression conditions compared 
to baseline free-to-tic conditions, although tic rates were signifi-
cantly higher during the breaks in the escape condition compared 
to non-break periods. Urge ratings were significantly higher during 
the reinforced tic suppression conditions compared to the baseline 
periods and in the escape condition, urge intensity went down from 
break onset to the end of a break. These results support the hypoth-
esis that premonitory urges are maintained through a process of 
negative reinforcement.
Many people with tics say that they perform tics to decrease the 
intensity of premonitory urges because the urges are so bother-
some. The relationship between feelings of discomfort and habitu-
ation was studied in 90 healthy undergraduate humans with no tic 
diagnosis34. A 2×2 experimental design was used with subjects either 
receiving an air puff to the eye or hearing a sound, and either receiv-
ing an instruction to blink or no instruction to blink. When subjects 
received the air puff and instructions to blink, the air puff was less 
annoying but the EMG response of the orbicularis oculi muscle 
continued and the length of the EMG response actually increased. 
When subjects received the air puff without any instructions about 
blinking, habituation to the air puff occurred. These results indi-
cated that blinking was reinforced by the decrease in annoyance 
and yet this process also prevented habituation from occurring. A 
similar process may establish the association between premonitory 
urges and tic behaviors; if so, this study may provide an interesting 
“animal” model of tics for certain studies.
Treatment-naive children and teenagers with chronic tic disorders 
were compared while being allowed to tic freely and while receiv-
ing reinforcement for suppressing their tics35. Attentional difficul-
ties and age did not affect ability to suppress tics. Interestingly, 
subjects were able to suppress tics associated with more intense 
urges just as much as tics associated with less intense urges.
The Premonitory Urge for Tics Scale (PUTS)36 has been the pri-
mary instrument for evaluating premonitory urges in children and 
adolescents. A 9 item version is frequently used because one item 
(“I am able to stop my tics, even if only for a short period of time”) 
did not correlate well with other test items. Interest in determining 
the reliability and validity in older adolescents and adults produced 
several studies that were published in 2014. The 10-item PUTS was 
completed by 102 adults at two specialist clinics. Again item 10 
demonstrated relatively low item-total correlation, consistent with 
the idea that tic suppression and premonitory urges may reflect dif-
ferent mental processes37. The PUTS total score correlated only 
slightly with scores on the Motor tic, Obsessions and Compulsions, 
Vocal tic Evaluation Survey (MOVES) (total 0.34, motor 0.28, 
vocal 0.27), supporting the view that tics and premonitory urges 
may involve different processes. In general, however, the PUTS was 
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considered to have acceptable reliability and validity when used 
with adults. Another study examined PUTS scores in 122 older ado-
lescents and adults with TS or CTD38. A third study examined the 
use of the PUTS in 100 adults with TS39. PUTS scores were related 
to obsessive-compulsive symptoms, anxiety, attentional problems 
and quality of life. Half of the total sample had “pure” TS while 
the other half had comorbid conditions (including 23 with OCD, 
15 with ADHD, and 6 with anxiety). For patients with “pure” TS, 
premonitory urges were negatively related to quality of life scores 
while a weaker relationship was seen between these two variables 
for patients with comorbid conditions. When stepwise multiple 
linear regression analyses were performed, PUTS scores for the 
“pure” subgroup were only predicted by MOVES obsessive-com-
pulsive subscale scores, while for the subgroup with comorbidities 
only anxiety scores were predictive of premonitory urges.
At this time the PUTS is the only empirically validated measure of 
premonitory urge severity. However, Capriotti et al. pointed out that 
the PUTS is relatively insensitive to change and is of limited valid-
ity in children under the age of 1033. They suggested the number 
of breaks taken during the tic suppression reinforcement + escape 
trials as an alternative way of measuring premonitory urge intensity. 
New approaches to quantifying urge intensity would be welcome.
What generates and maintains tics? Two stress-induction tasks 
(i.e., public speech, discussion of family conflict) were used to 
study 8 TS children with comorbid anxiety40. Tic frequency did not 
increase during periods of increased heart rate, and during the pub-
lic speech task tic frequencies were actually lower during periods 
of increased heart rate. The authors point out the only psychophysi-
ological measure of stress used in this study was heart rate and that 
future studies may benefit from simultaneously assessing a variety 
of measures of stress (e.g., respiratory rate, ECG, eye tracking) and 
examining effects on premonitory urge intensity in addition to tic 
occurrence.
They went away. Shprecher et al. reported a retrospective follow-up 
study of tic remission41. A brief survey was used to assess current 
symptoms of 53 TS patients who were 13–31 years old and had 
been seen previously in a TS clinic. At the time of the follow-up 
subjects were seen in person or contacted by telephone. The survey 
results were consistent with past research about TS and comorbid 
ADHD and OCD. Mean symptom onset was age 7.9 for both tics 
and ADHD and 9.2 for OCD. Peak symptom severity was reported 
to be around age 11–13 for all three conditions with a decline in 
symptom severity beginning around age 14–15. Symptom remis-
sion was reported in 32%, 23%, and 21% of subjects for tics, 
ADHD, and OCD respectively.
Limited longitudinal follow-up data are available for tic disorders 
other than TS. Bisker and colleagues reviewed 43 children with 
no prior diagnosis of Tourette syndrome who had been diagnosed 
with ocular tics by a pediatric neuro-ophthalmologist42. An average 
of 6 years after their initial consultation, 32 of the children were 
located for follow-up. Of these, 44% had persistent ocular tics, 9% 
had developed nonocular motor tics, and 16% had developed both 
nonocular motor tics and vocal tics. In other words, the tic disorder 
remitted in less than a third of the patients available for follow-up.
Treatment
Medication. The effectiveness of dopamine D2-like receptor antag-
onists for treating tics is well-established46,72. Recently ecopipam, 
a selective D1 receptor antagonist, was used in an 8-week open-
label study in 18 TS adults, 15 of whom completed the study73. 
The mean YGTSS total tic score decreased from 30.6 at baseline 
to 25.3 at the end of the trial. There was no worsening of ADHD or 
OCD symptoms. Interestingly, there was no change in the intensity 
of premonitory urges as measured by the PUTS scale, suggesting 
that patients may have felt more able to resist the urges to perform 
tics. There was no weight gain associated with taking ecopipam, 
as is seen with most D2 antagonists. The results of this pilot study 
suggest the value of conducting a larger double-blind study. Given 
that this medication has a different mechanism of action than the 
medications currently available to treat tics, it may prove useful for 
the nontrivial number of patients who have responded inadequately 
to currently available medications.
Wijemanne et al.74 provide a retrospective chart review of patients 
treated with fluphenazine at a movement disorders referral center 
over a 26-year period. Fluphenazine is a high-potency typical antip-
sychotic. Only patients who had at least one follow-up office visit 
or telephone interview were included in the study. A total of 268 
patients were included in the study; they had taken a mean daily flu-
phenazine dose of 3.24 mg for an average of 2.6 years. Improvement 
was judged to be moderate to marked in four fifths of patients, with 
side effects in one fourth. Tardive dyskinesia was not observed.
Deep brain stimulation. Deep brain stimulation (DBS) is a promising 
treatment option for highly selected TS patients refractory to more 
conservative treatments50,75. Several reports published in 2014 pro-
vide open-label follow-up on deep brain stimulation (DBS) in more 
than a few TS patients. Several groups had targeted the internal seg-
ment of the globus pallidus (GPi)76–78. At follow-up intervals of from 
8 to 80 months, most patients tolerated the treatment well and mean 
symptomatic improvement compared to pre-surgery was 40–50%. 
Another group reported open-label 6- and 12-month follow-up of 8 
patients after DBS to the ventral anterior and ventrolateral thalamus79.
Angelov and colleagues80 studied DBS in rats bred for high prepulse 
inhibition (PPI) of the startle reflex, an electrophysiological marker 
that is elevated in TS and some other illnesses. This allowed direct 
comparison of results (in terms of PPI reduction) among several dif-
ferent previously proposed target sites for DBS in TS. They found 
that thalamic stimulation (of the centromedian-parafascicular com-
plex) best reduced PPI and nucleus accumbens less so. Importantly, 
implantation of leads in the entopeduncular nucleus (the rodent 
homolog of the primate GPi) reduced PPI, but DBS itself added no 
additional benefit; this result helps demonstrate why randomized, 
blinded studies are crucial in evaluating invasive treatments.
Behavior therapy really works. Behavior therapy has been stud-
ied as a treatment for tics for many years26. However, its adoption 
in clinical practice has lagged for a number of reasons27. A meta-
analysis that appeared in 2014 may help convince skeptics of its 
efficacy. The meta-analysis included 8 randomized control trials of 
TS behavior therapy with a total of 438 TS subjects28. There was no 
evidence of publication bias. Treatment effects were in the medium 
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to large range, with a number needed to treat (NNT) of only 3, com-
parable to the most effective class of medications (antipsychotics). 
Participants who were more likely to respond to behavior therapy 
were older, had more therapeutic contact and were less likely to 
have comorbid ADHD. At this point, the evidence base for behavior 
therapy’s efficacy in treating tics is stronger than for any other class 
of treatments except antipsychotics26.
Although research continues to demonstrate the value of behavioral 
treatments such as CBIT, a limited number of therapists have been 
trained to administer CBIT. Given the distance that many patients 
live from potential therapists there is a need for alternative forms of 
treatment. Blount et al. reported on treatment administered using an 
intensive outpatient procedure (i.e., several hours daily over a four 
day period) to two pediatric outpatients. This treatment resulted in 
significant tic reductions that were maintained at follow-up 6 to 
7 months later29. This form of treatment may be more convenient 
for patients and their families who need to travel a significant dis-
tance for treatment, but a randomized controlled trial will be needed 
to replicate these promising results.
Do exercise and biofeedback work? A small group of 18 partici-
pants, ranging in age from 10 to 20 years old, performed an Xbox® 
kickboxing exercise routine with a 5-minute easy exercise session 
followed by a 2-minute break and then a 5-minute exercise session 
that was more physically demanding30. Tic counts based on video 
recordings were lower during both exercise sessions compared to 
during a baseline interview (i.e., completion of the Physical Activity 
Questionnaire for Adolescents, discussion about hobbies and other 
leisure activities). Interestingly, tic frequency was higher during the 
more demanding exercise session (which also occurred after the sub-
jects had been exercising for a longer amount of time) than during 
the easier exercise session. Although tic frequency increased signifi-
cantly during a second interview completed about 30 minutes after 
the end of the exercise sessions, the frequency was still below that 
seen during the pre-exercise baseline. Exercise also resulted in sig-
nificantly reduced self-reported anxiety which was maintained dur-
ing the post-exercise interview. It was suggested that exercise might 
have been effective in reducing tic frequency because it improved 
executive control functions, or because it served as a distraction task 
taking attention away from the tics, or because exercise functioned 
as a competing response which made it more difficult to perform the 
tics. Behavioral treatments, such as CBIT, tend to involve multiple 
components and, consequently, it is difficult to determine whether 
all components are necessary for all patients. Using a simple inter-
vention such as that used by Nixon et al. may make it easier to iden-
tify the underlying mechanism that makes the intervention effective 
and may help identify whether certain patient subgroups are more 
likely to respond to a particular treatment component.
A preliminary randomized controlled trial examined electroder-
mal biofeedback during three 30-minutes sessions each week for 
4 weeks in 21 adults with TS31. Both sham and actual biofeedback 
produced similar decreases in tic frequency and similar improve-
ments in well-being. The authors noted that tics occurring during 
the biofeedback sessions resulted in competing phasic electrodermal 
arousal responses making it difficult for patients to sustain a reduc-
tion in sympathetic tone, suggesting that modifications in the treat-
ment protocol might increase effectiveness. The sham procedure, 
which involved providing feedback to subjects so that they thought 
that they were successfully altering their electrodermal activity, also 
resulted in a significant decrease in tics. This is surprising since 
placebo effects are minimal in pharmacological trials32.
Old and new
The most recent International Scientific Symposium on Tourette 
Syndrome (New York, 2009) led to a set of review articles on TS 
updated for publication in 201427,43–50. Also in 2014 the Tourette 
Association of America announced that it had joined with two 
European TS groups to sponsor the “First World Congress on 
Tourette Syndrome and Tic Disorders”, held in London in June, 
2015 (http://touretteworldcongress.org). Finally, it is difficult to 
resist pointing out that 2014 also marked the introduction of a pub-
lication channel devoted entirely to tics, F1000Research: Tics51. 
New submissions are warmly invited!
Discussion
We have provided summaries of some of the articles published in 
2014 that we think will contribute to further advances in the field. 
They cover a variety of topics: genetics, animal models, neuroimag-
ing, and pharmacological and nonpharmacological treatment. The 
choice of articles was admittedly subjective and most likely incom-
plete; in fact, we have listed a few more papers in Box 1. However, 
one of the beauties of this publication venue is that readers who feel 
we have misjudged are welcome to add their own recommendations 
to the comments section of this article online.
We look forward to reprising this “highlights” page at the end of 
2015, and would be grateful for article nominations or other sug-
gestions from readers. Box 2 starts off this process by listing some 
meeting presentations and preprints that caught our interest but had 
Box 1. Additional 2014 publications of interest
“Altered synaptic plasticity in Tourette’s Syndrome and its 
relationship to motor skill learning”52
“Environmental circumstances influencing tic expression in 
children”53
“The modulating role of stress in the onset and course of 
Tourette’s Syndrome: A review”54
“Tic-related obsessive-compulsive disorder (OCD): 
Phenomenology and treatment outcome in the Pediatric OCD 
Treatment Study II”55
“Set-shifting deficits: A possible neurocognitive endophenotype 
for Tourette Syndrome without ADHD”56
“Variables associated with tic exacerbations in children with 
chronic tic disorders”57
Prenatal and perinatal risk factors for TS58
Prenatal risk factors for TS81
“Tics are caused by alterations in prefrontal areas, thalamus and 
putamen, while changes in the cingulate gyrus reflect secondary 
compensatory mechanisms”59
“Meta-cognitions in Tourette syndrome, tic disorders, and  
body-focused repetitive disorder”60
“Dysregulated intracellular signaling in the striatum in a 
pathophysiologically grounded model of Tourette syndrome”61
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not appeared in final form by the end of 2014. We hope that 2015 
brings important breakthroughs in our understanding of the causes, 
mechanisms and treatment of tic disorders.
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Deep brain stimulation for TS75
Deep repetitive transcranial magnetic stimulation to the 
supplementary motor area82
Neurofeedback and TS83
Psychiatric comorbidity in TS84
Current medication treatment of TS in Germany85
Parenting stress in TS86
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found in the second study or do the results in the last paragraph refer to the second AND third study?
 
I have two more suggestions for Box 1:
 
Muller-Vahl, K. R., Riemann, L., & Bokemeyer, S. (2014). Tourette patients' misbelief of a tic rebound is
. J Psychosom Res, 76, 472-476.due to overall difficulties in reliable tic rating
 
Gharatya, A., Stern, J., Man, C., Williams, D., Simmons, H., & Robertson, M. (2014). Suicidality in
J Neurol Neurosurg Psychiatry, 85, e3.patients with tourette's syndrome. 
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response (  ) 06 Aug 2015F1000Research Advisory Board Member
, Department of Psychiatry, Washington University in St. Louis, USAKevin J Black
We thank Dr. Brandt for her thoughtful comments. 
 No competing interests were disclosed.Competing Interests:
Version 1
 29 April 2015Referee Report
doi:10.5256/f1000research.6659.r7989
 Barbara Coffey
Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA
The authors report on highlights of the growing medical and scientific literature on Tourette Syndrome in
2014. The aim was not to conduct a systematic review, but instead to discuss noteworthy articles of
interest. Topics ranged from animal models and neuroimaging to behavioral treatment.
 
Strengths of this manuscript were 1) cogent and thoughtful summary/discussion of the articles, 2) an
informal and readable style, and 3) interesting content. There were several weaknesses, which if
addressed, would strengthen the manuscript.
 
Methods: it would be helpful to know the approximate denominator of articles reviewed, and what
proportion were selected.
 
Results: it would be helpful to know how/why topic areas were chosen. Weight seemed to lean strongly
toward neuroimaging, which may reflect the authors’ primary interests and expertise. Organization of topic
areas could be improved; as it stands, the reader is moved from neuroscience (animal models, imaging)
to behavior therapy, premonitory urges, and longitudinal course, and then back to neuroscience
(genetics). It might read more easily to start with basics (neuroscience, genetics, neuroimaging) through
phenomenology (course, urges, role of stress) to treatment.
 
The manuscript could be improved with the inclusion of pharmacotherapy updates; although the
Discussion summarized that the “broad spectrum of articles” covered “animal models, neuroimaging, and
pharmacological and non-pharmacological treatment,” the only treatments discussed were behavior
therapy, exercise and biofeedback.
 
Suggested pharmacotherapy additions include:
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Gilbert, D. “ ” Clinet al.: A D1 receptor antagonist, ecopipam, for treatment of tics in Tourette Syndrome
Neuropharmacol 2014; 37 (1) 26-30
Malaty, I.A. and Akbar U: ; 2014; CurrUpdates in Medical and Surgical Therapies for Tourette Syndrome
Neurol Neurosci Rep 14: 458; this is a review with an annotated bibliography.
 
Work to look for in 2015: Bachmann, CJ et al.: Trends in Psychopharmacological Treatment of Tic
; Eur Child Adolesc Psychiatry 2015; 24 (2); 199-207Disorders in Children and Adolescents in Germany
Lastly, there appeared to be a relative lack of articles on aspects of psychiatric comorbidity. Of particular
interest is the recently published study from the Tourette Syndrome Association International Consortium
for Genetics:
 
Hirschtritt, M. .: et al Lifetime Prevalence, Age of Risk, and Genetic Relationships of Comorbid Psychiatric
; doi:10.1001/jamapsychiatry.2014.2650Disorders in Tourette Syndrome  JAMA Psychiatry 
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response (  ) 30 Jun 2015F1000Research Advisory Board Member
, Department of Psychiatry, Washington University in St. Louis, USAKevin J Black
We thank Dr. Coffey for her very thoughtful comments, and have revised the manuscript
accordingly. Replies to specific comments follow.
Requests the “approximate denominator of articles reviewed.”
We read at least the abstract from the 200 papers identified in the PubMed searches. We
have added this number to the introduction. We cite well over 50 of them. Originally we
intended to discuss only about 5 or 10 papers, but it was harder than expected to omit
anything.
 
“It would be helpful to know how/why topic areas were chosen … may reflect the
authors’ primary interests”
Doubtless the selection of articles reflects some influence of our own interests. As you
noted, we at least warned the reader that our selection was arbitrary. We attempted to
respond to the theme of what reports were most likely to be of greatest interest in the future,
and we now explain this choice in the first sentence of Results.
 
“Organization of topic areas could be improved”
Thank you for the useful suggestion. We have rearranged the topics in a more structured
fashion: Etiology, pathophysiology, phenomenology and natural history, and treatment.
 
We left out pharmacology
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We left out pharmacology
We agree. Please see our comments in the response to Dr. Martino's review about Gilbert et
We have added the Malaty and Akbar citation to the treatment section, and theal. 
Bachmann review to Box 2.et al. 
 
“Relative lack of articles on … psychiatric comorbidity.” Recommends Hirschtritt et
2015.al. 
We are also very interested in psychiatric comorbidity, and we agree that the Hirschtritt et al
article is very important. As it was published in April, 2015, we added it to Box 2.
 No competing interests were disclosed.Competing Interests:
 21 April 2015Referee Report
doi:10.5256/f1000research.6659.r8212
 Davide Martino
Department of Neurology, King's College London, Hospital NHS Foundation Trust, London, UK
I enjoyed reading this useful and well written contribution.
I have a few comments:
In the subsection of Results entitled “Other animal models”, the reader might benefit from a brief
explanation of the model presented by McCairn et al: did this use a GABA antagonist like
bicuculline?
 
In the subsection entitled “A look inside: neuroimaging studies”, I personally found interesting a
paper which is not cited and evaluates the potential of deep repetitive transcranial magnetic
stimulation (deep rTMS) to the supplementary motor area ( )Bloch .,2014et al
 
In respect to neurobiofeedback, as commented on in page 4, another useful paper on ADHD and
tic disorders is . Moreover, a 2015 citation focusing on neurofeedback isGevensleben (2009)et al. 
this useful review: .Farkas . (2015)et al
 
My main criticism is that there is no citation at all about deep brain stimulation, which is an area
currently avidly investigated in Tourette syndrome. It is possible that the authors felt that none of
the articles published in 2014 on DBS in Tourette syndrome is sufficiently interesting, but I would at
least discuss this in the article and add the following citation in Box 2: .Schrock ., (2015)et al
 
Additional 2014 publications of interest:
Chao TK, Hu J and Pringsheim T: Prenatal risk factors for Tourette syndrome: a systematic review.
2014; (53).BMC Pregnancy and Childbirth. 14
Gilbert DL, Budman CL, Singer HS, :, A D1 receptor antagonist, ecopipam, for treatment inet al
Tourette syndrome. 2014; (1): 26-30.Clin Neuropharmacol. 37
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Tourette syndrome. 2014; (1): 26-30.Clin Neuropharmacol. 37
Wijemanne S, Wu LJ and Jankovic J: Long-term efficacy and safety of fluphenazine in patients
with Tourette syndrome. 2014; (1):126-130.Mov Disord. 29
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response (  ) 30 Jun 2015F1000Research Advisory Board Member
, Department of Psychiatry, Washington University in St. Louis, USAKevin J Black
We appreciate Dr. Martino's thoughtful comments and have used them to improve the manuscript
for version 2.
Brief explanation of the model presented by McCairn et al.
Yes, this used bicuculline injected into the putamen or nucleus accumbens; we have added
this to the manuscript.
 
Recommends Bloch et al.
This is a very interesting article, but the final version was not yet published as of May, 2015.
We have added it to Box 2.
 
"In respect to neurobiofeedback, as commented on in page 4, another useful paper
on ADHD and tic disorders is . Moreover, a 2015 citationGevensleben  (2009)et al.
focusing on neurofeedback is this useful review: ."Farkas . (2015)et al
Good articles. Readers can find the citation to Gevensleben 2009 in your comments.et al. 
We have added the Farkas (2015) reference to Box 2.et al. 
 
No citation about DBS.
We agree this is an important area of work in TS, but relatively few DBS papers on TS were
published in 2014. We have added a paragraph on DBS, and have added the important
2015 paper you suggested to Box 2.
 
Recommends Chao , prenatal risk factors for Tourette syndromeet al.
We agree and have added this to Box 1.
Recommends Gilbert , ecopipam studyet al.
This paper was overlooked by accident. We agree this was an important pilot study on a
potentially new avenue of treatment for TS and have added a short paragraph.
Recommends Wijemanne , fluphenazine report.et al.
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5.  
Recommends Wijemanne , fluphenazine report.et al.
Thank you. We have added this to the section on medication treatment.
 No competing interests were disclosed.Competing Interests:
Discuss this Article
Version 2
Author Response (  ) 08 Oct 2015F1000Research Advisory Board Member
, Department of Psychiatry, Washington University in St. Louis, USAKevin J Black
We have begun  of a 2015 update of this article, and would be grateful for any constructivean online draft
feedback. The platform allows readers to leave comments on the little balloon icon at the upper right
corner of each section of the article.
I'm thinking about allowing "in press" and "Epub ahead of print" articles this year. It has obvious benefits for
timeliness, so I should explain why I didn't in the 2014 article above. I did not want to collude with journals
that exploit increasing delays in their "official" paper publication dates to increase journal impact factor
while simultaneously delaying free access to the public on PubMedCentral. Given the timely publication
benefit of F1000Research, such delays increasingly rankle.
 No competing interests were disclosed.Competing Interests:
Author Response (  ) 19 Jul 2015F1000Research Advisory Board Member
, Department of Psychiatry, Washington University in St. Louis, USAKevin J Black
I omitted this citation for the matplotlib library used in creating Figure 1:
.Hunter JD: Matplotlib: A 2D graphics environment. Computing In Science & Engineering 9(3):90-95, 2007
 No competing interests were disclosed.Competing Interests:
Version 1
Author Response (  ) 17 Mar 2015F1000Research Advisory Board Member
, Department of Psychiatry, Washington University in St. Louis, USAKevin J Black
The (U.S.) Tourette Syndrome Association highlights some articles a couple of times a year in their
newsletter. Their focus overlaps ours. Their links are here.
 noneCompeting Interests:
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Author Response (  ) 16 Mar 2015F1000Research Advisory Board Member
, Department of Psychiatry, Washington University in St. Louis, USAKevin J Black
Here's another contribution to Box 2 (articles to look for in 2015). This interesting article from my
colleagues and mentee just appeared in "online early" form:
Stewart SB, Greene DJ, Lessov-Schlaggar CN, Church JA, Schlaggar BL: Clinical correlates of parenting
stress in children with Tourette syndrome and in typically developing children. 
doi:10.1016/j.jpeds.2015.01.041
 ColleaguesCompeting Interests:
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